13F filer · CIK 1937964
Artia Global Partners LP
MIAMI, FL · filing since Q4 2022 · last filing Aug 14, 2026
Reported value
$541.9M
+$42.4M vs prior
Positions
48
New / sold out
8 / 10
Added / reduced
11 / 3
Turnover
24.1%
buys $141.0M · sells $125.3M
Top-10 weight
64.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | BRIGHTSPRING HEALTH SVCS INC | +463,515 | +861.6% | +$32.3M |
| New | ALKERMES PLC | +448,964 | – | +$23.5M |
| New | SPDR SERIES TRUSTPUT | +100,000 | – | +$15.8M |
| Added | TRAVERE THERAPEUTICS INC | +268,333 | +379.5% | +$15.2M |
| Added | REVOLUTION MEDICINES INC | +60,400 | +48.3% | +$11.3M |
| New | GUARDANT HEALTH INC | +38,100 | – | +$5.7M |
| New | ABSCI CORPORATION | +464,444 | – | +$5.4M |
| Added | QUEST DIAGNOSTICS INC | +24,305 | +59.5% | +$5.2M |
| New | ASCENDIS PHARMA A/S | +17,740 | – | +$4.7M |
| Added | CYTOKINETICS INC | +54,400 | +333.7% | +$4.6M |
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | INSMED INCPUT | -279,700 | -100.0% | $-45.7M |
| Sold out | LLYELI LILLY & CO | -38,220 | -100.0% | $-35.2M |
| Reduced | ABIVAX SA | -84,300 | -14.0% | $-11.2M |
| Sold out | MODERNA INCCALL | -200,000 | -100.0% | $-10.2M |
| Sold out | TERNS PHARMACEUTICALS INC | -104,800 | -100.0% | $-5.5M |
| Reduced | INSMED INC | -39,660 | -6.3% | $-4.2M |
| Sold out | ASCENDIS PHARMA A/S | -17,740 | -100.0% | $-4.1M |
| Sold out | ABBVIE INC | -14,500 | -100.0% | $-3.2M |
| Sold out | SOLENO THERAPEUTICS INC | -68,490 | -100.0% | $-2.3M |
| Sold out | BRIDGEBIO PHARMA INC | -20,400 | -100.0% | $-1.5M |
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ABIVAX SASPONSORED ADS | 516,447 | $68.8M | 12.70% |
| 2 | INSMED INCCOM PAR $.01 | 589,052 | $62.8M | 11.59% |
| 3 | TREVI THERAPEUTICS INCCOM | 2,210,852 | $41.2M | 7.61% |
| 4 | BRIGHTSPRING HEALTH SVCS INCCOM | 517,315 | $36.1M | 6.66% |
| 5 | REVOLUTION MEDICINES INCCOM | 185,390 | $34.7M | 6.41% |
| 6 | ARGENX SESPONSORED ADR | 29,739 | $27.6M | 5.09% |
| 7 | ALKERMES PLCSHS | 448,964 | $23.5M | 4.34% |
| 8 | TRAVERE THERAPEUTICS INCCOM | 339,033 | $19.3M | 3.55% |
| 9 | ASTRAZENECA PLCORD | 98,376 | $18.7M | 3.44% |
| 10 | NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES | 503,936 | $17.1M | 3.15% |
38 more rows. Subscribe for $29/month to see every row, download the data and use the API.